Eid2 - EP300 interacting inhibitor of differentiation 2 Gene
Also Known as Cri2; EID-2
Species: Mus musculus
Summary
Predicted to enable SMAD binding activity and transcription corepressor activity. Predicted to be involved in several processes, including negative regulation of transcription, DNA-templated; negative regulation of transforming growth factor beta receptor signaling pathway; and transmembrane receptor protein serine/threonine kinase signaling pathway. Predicted to act upstream of or within negative regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. Predicted to be active in nucleoplasm. Is expressed in brain; embryo; heart; metanephros; and pancreas. Orthologous to human EID2 (EP300 interacting inhibitor of differentiation 2). [provided by Alliance of Genome Resources, Apr 2022]
Eid2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_198425.2 | NP_940817.1 | EP300-interacting inhibitor of differentiation 2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
EP300-interacting inhibitor of differentiation 2 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS04235 | EID2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18755 | Eid2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25242 | Eid2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service